C-TRACT Study Site Questionnaire C-Tract Study Site Questionnaire KEY PERSONNEL CONTACT INFORMATION Name of Site Address Address Address Address City City State/Province State/Province Zip/Postal Zip/Postal Country AfghanistanAland IslandsAlbaniaAlgeriaAmerican SamoaAndorraAngolaAnguillaAntarcticaAntigua and BarbudaArgentinaArmeniaArubaAustraliaAustriaAzerbaijanBahamasBahrainBangladeshBarbadosBelarusBelgiumBelizeBeninBermudaBhutanBoliviaBonaire, Sint Eustatius and SabaBosnia and HerzegovinaBotswanaBouvet IslandBrazilBritish Indian Ocean TerritoryBruneiBulgariaBurkina FasoBurundiCôte d'IvoireCambodiaCameroonCanadaCape VerdeCayman IslandsCentral African RepublicChadChileChinaChristmas IslandCocos (Keeling) IslandsColombiaComorosCongoCook IslandsCosta RicaCroatiaCubaCuracaoCyprusCzech RepublicDenmarkDjiboutiDominicaDominican RepublicEast TimorEcuadorEgyptEl SalvadorEquatorial GuineaEritreaEstoniaEthiopiaFalkland Islands (Malvinas)Faroe IslandsFijiFinlandFranceFrench GuianaFrench PolynesiaFrench Southern TerritoriesGabonGambiaGeorgiaGermanyGhanaGibraltarGreeceGreenlandGrenadaGuadeloupeGuamGuatemalaGuernseyGuineaGuinea-BissauGuyanaHaitiHeard Island and McDonald IslandsHoly SeeHondurasHong KongHungaryIcelandIndiaIndonesiaIranIraqIrelandIsle of ManIsraelItalyJamaicaJapanJerseyJordanKazakhstanKenyaKiribatiKosovoKuwaitKyrgyzstanLaosLatviaLebanonLesothoLiberiaLibyaLiechtensteinLithuaniaLuxembourgMacaoMacedoniaMadagascarMalawiMalaysiaMaldivesMaliMaltaMarshall IslandsMartiniqueMauritaniaMauritiusMayotteMexicoMicronesiaMoldovaMonacoMongoliaMontenegroMontserratMoroccoMozambiqueMyanmarNamibiaNauruNepalNetherlandsNew CaledoniaNew ZealandNicaraguaNigerNigeriaNiueNorfolk IslandNorth KoreaNorthern Mariana IslandsNorwayOmanPakistanPalauPalestinePanamaPapua New GuineaParaguayPeruPhilippinesPitcairnPolandPortugalPuerto RicoQatarReunionRomaniaRussiaRwandaSaint BarthelemySaint Helena, Ascension and Tristan da CunhaSaint Kitts and NevisSaint LuciaSaint Martin (French part)Saint Pierre and MiquelonSaint Vincent and the GrenadinesSamoaSan MarinoSao Tome and PrincipeSaudi ArabiaSenegalSerbiaSeychellesSierra LeoneSingaporeSint Maarten (Dutch part)SlovakiaSloveniaSolomon IslandsSomaliaSouth AfricaSouth Georgia and the South Sandwich IslandsSouth KoreaSouth SudanSpainSri LankaSudanSurinameSvalbard and Jan MayenSwazilandSwedenSwitzerlandSyriaTaiwanTajikistanTanzaniaThailandTimor-LesteTogoTokelauTongaTrinidad and TobagoTunisiaTurkeyTurkmenistanTurks and Caicos IslandsTuvaluUgandaUkraineUnited Arab EmiratesUnited KingdomUnited StatesUnited States Minor Outlying IslandsUruguayUzbekistanVanuatuVatican CityVenezuelaVietnamVirgin Islands, BritishVirgin Islands, U.S.Wallis and FutunaWestern SaharaYemenZambiaZimbabwe Country Primary Contact Person First and Last Name Email Address Phone Number Site Principal Investigator (PI) Email Address Phone Number PI Subspecialty FACILITY INFORMATION Please list the Primary Hospital at which you plan to enroll patients, as well as up to two major affiliate hospital that fall within your IRB’s jurisdiction. Primary Hospital Estimated yearly number of DVT Cases (irrespective of treatment type) Estimated yearly number of patients with moderate-severe PTS (any treatment type) Affiliate Hospital #1 Which category best describes the nature of your Primary Hospital? University Hospital Community Hospital with Strong Academic Affiliation Private Hospital without Strong Academic Affiliation OtherOther Which of the following categories best describes the nature of Affiliate Hospital #1? University Hospital Community Hospital with Strong Academic Affiliation Private Hospital without Strong Academic Affiliation Affiliate Hospital #2 Which of the following categories best describes the nature of Affiliate Hospital #2 University Hospital Community Hospital with Strong Academic Affiliation Private Hospital without Strong Academic Affilation Wound or Ulcer Care Clinic Yearly number of patients seen RESEARCH COORDINATOR INFORMATION Research Coordinator First and Last Name Email Address Phone Number Number of Years Research Experience ENDOVASCULAR THERAPY (EVT) Primary Endovascular Co-Investigator (will oversee EVT) First and Last Name Email Address Phone Number Subspecialty Number of years since completion of training How many iliac vein stent procedures are performed in the group yearly? How many are for treatment of chronic DVT with moderate-severe PTS? What stent do you prefer? MEDICAL AND COMPRESSIVE PTS THERAPY Primary Medical Co-Investigator (will oversee standard PTS care) First and Last Name Email Address Phone Number Subspecialty Number of years since completion of training VENOUS ULCER CARE Primary Ulcer Care Co-Investigator (will oversee venous ulcer care) First and Last Name Email Address Phone Number Subspecialty Number of years since completion of training How many venous ulcers has this investigator managed? SITE-SPECIFIC ENROLLMENT AND DATA COLLECTION Is your research team willing to engage in an active ongoing quality improvement program with study leadership to maximize the potential for enrollment? Yes No Have you or your institution utilized electronic (e.g. EHR-based or electronic queries of other databases) methods of identifying patients for clinical research? Yes No If yes, please specify Vascular Ultrasound capabilities: Is your ultrasound lab willing to identify patients for the C-TRACT study? Yes No Is your ultrasound lab willing to complete web-based training to become qualified to submit ultrasound exams for study patients to a core lab? Yes No Venogram Imaging capabilities: Is your angiography lab willing and able to transfer pre- and post-procedure venograms to a core lab using a DICOM-compatible interface? Yes No COMPETITIVE ENROLLMENT Please name any studies at your site that expect to enroll patients with DVT or PTS from 2017-2020, and indicate how problems with competitive enrollment will be avoided. STATEMENT OF CLINICAL EQUIPOISE Does each co-investigator accept the premise that it is ethical and appropriate to randomize patients with moderate-severe PTS (including patients with venous ulcers less than 6 cm) to receive either EVT or no EVT in a trial (along with medical therapy, compression, and venous ulcer care as needed), and maintain them in their assigned treatment arm for 6-18 months (with rare exceptions)? YES No Maybe If the answer to this question is anything but an unequivocal YES, please explain Email This form is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply. Submit Δ